JM Financial Recommends Buying GPT Healthcare, Targets Rs 245

JM Financial has advised investors to purchase shares of GPT Healthcare Ltd. with a target price set at Rs 245. Currently, the market price stands at Rs 167.6.

Company Overview

GPT Healthcare Ltd., established in 1989, operates as a large-cap company in the general sector, with a market capitalization of Rs 1,356.86 crore.

Products and Revenue

The company’s primary revenue segments include healthcare services, pharmaceuticals, and other operational activities for the fiscal year ending March 31, 2024.

Financial Performance

For the quarter ending March 31, 2024, GPT Healthcare Ltd. reported a standalone total income of Rs 101.02 crore. This marks a 3.32% increase from Rs 97.77 crore in the previous quarter and a 2.64% increase from Rs 98.41 crore in the same quarter last year. The company achieved a net profit after tax of Rs 12.82 crore in the latest quarter.

Ownership Structure

As of March 31, 2024, promoters hold a 65.57% stake in the company, while Foreign Institutional Investors (FIIs) own 6.68% and Domestic Institutional Investors (DIIs) hold 11.61%.

JM Financial’s recommendation reflects confidence in GPT Healthcare Ltd.’s financial performance and growth potential within the healthcare sector.